Table 2 Comparison between the studied groups regarding sex and age distribution, laboratory parameters, and disease activity score
From: Clinical significance of red blood cell distribution width in systemic lupus erythematosus patients
Characteristics | Active SLE | Inactive | Control | p value |
|---|---|---|---|---|
Male | (7) 23.3% | (1) 3.3 | (11) 36.7% | Male/female |
Female | (23) 76.7% | (29) 96.7 | (19) 63.3% | 0.006 (S) |
Age | 34.83 ± 10.49 | 34.23 ± 9.26 | 34.53 ± 8.569 | 0.992 (NS) |
CBC | ||||
WBCs | 7.02 ± 3.12 | 7.49 ± 3.29 | 8.13 ± 3.16 | 0.402 |
Hg | 11.87 ± 1.8 | 12.15 ± 1. | 12.2 ± 1.9 | 0.651 |
PLts | 269.6 ± 97 | 276.3 ± 78 | 264 ± 66.6 | 0.843 |
Lymphocytes | 20.9 ± 9.1 | 27.0 ± 8.3 | 26.6 ± 12.7 | 0.04 (S) |
Neutrophils | 72.1 ± 12 | 65.6 ± 9.1 | 65.4 ± 13.9 | 0.05 (S) |
Monocytes | 5.06 ± 3.4 | 5.35 ± 1.7 | 7.2 ± 12.3 | 0.48 |
Basophils | 0.33 ± 0.40 | 0.15 ± 0.26 | 0.37 ± 0.55 | 0.09 |
Eosinophil | 1.12 ± 1.15 | 1.65 ± 1.44 | 2.48 ± 2.93 | 0.03 (S) |
RDW-CV% | 16.64 ± 4.7 | 13.16 ± 2.67 | 12.7 ± 1.13 | < 0.001 (HS) |
24 urine proteins | 1207.4 | 183.62 | 77.80 | < 0.001 (HS) |
C3 | 88.8 ± 40.2 | 116.7 ± 23.7 | 163.1 ± 27.01 | 0.03 |
C4 | 15.4 ± 15.4 | 19.3 ± 12.4 | 17.7 ± 18.8 | 0.02 |
Serum creatinine | 0.76 ± 0.30 | 0.72 ± 0.28 | 0.80 ± 0.27 | 0.543 |
ESR | 55.1 ± 29.5 | 47.0 ± 35.5 | 31.6 ± 11.8 | 0.002 |
ANA | (30) 100.0% | (26) 86.7% | (0) .0% | 0.001 (HS) |
Anti-ds DNA | 73.3% | 46.7% | (0) .0% | 0.001 (HS) |
SLEDAI score | 8.43 ± 4.1 | 1.143 ± 0.41 | 0 ± 0 | < 0.001 (HS) |
Renal biopsy | 37.9% class II | 23.3% class II | 0 ± 0 | 0.004 (S) |
26.7% class V | 10% class V | |||